Objectives We aimed to study the efficacy of reduced intensity conditioning (RIC) allo‐HSCT
combined with anti‐thymocyte globulin (ATG) and post‐transplant cyclophosphamide …

Background Graft-versus-host disease (GVHD) remains a major contributor to mortality and
morbidity after allogeneic stem-cell transplantation (allo-HSCT). The updated …

Background: Allogeneic hematopoietic cell transplantation (HCT) is curative for high-risk
acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but with significant …

In this registry-based study which includes acute myeloid leukemia patients who underwent
a matched unrelated donor allogeneic peripheral-blood stem cell transplantation in …

In the evolution of haploidentical hematopoietic stem cell transplantation (haplo-HSCT), In
vivo T-cell modulation with concomitant use of anti-thymocyte globulin (ATG) and high-dose …

The impact of the intensity of graft-versus-host-disease immunoprophylaxis on
transplantation outcomes in patients undergoing transplantation following reduced-intensity …

In haploidentical peripheral blood stem cell transplantation (haplo-PBSCT), the combination
of anti-thymocyte globulin and post-transplant cyclophosphamide (ATG/PTCy) has a …

Post-transplant cyclophosphamide (PTCy) is being increasingly used as graft-versus-host
disease (GVHD) prophylaxis post allogeneic hematopoietic stem cell transplantation (allo …

Allogeneic hematopoietic stem cell transplantation (HSCT) could be the only curative
therapy for patients with relapsed/refractory acute leukemia (RRAL). Many reports have …

Post-transplant cyclophosphamide plus calcineurin inhibitor (CNI)(tacrolimus or
cyclosporine A) plus mycophenolate mofetil (PTCy/TAC or CSA/MMF) and anti-thymocyte …